FDA Inspection 1215025 — Anastasia Kelidou, MD
The FDA completed an inspection of Anastasia Kelidou, MD on May 26, 2023 in Hamburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hamburg (Germany)
Additional Details
Clinical BA/BE